These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 964523)

  • 21. [Successful resuscitation from sudden death caused by Cavinton].
    Hutter K; Deli L; Csomós I
    Orv Hetil; 1980 Feb; 121(7):397-8. PubMed ID: 7375104
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vincapront Retard in geriatrics. Results of a multicenter study on patients with organic psychoses].
    Hinkelmann B; Bentel U; Hangleiter P; Maisenbacher J
    MMW Munch Med Wochenschr; 1979 Oct; 121(43):1427-8. PubMed ID: 119913
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cerebral circulation and various indices of the functional status of the brain during aging].
    Mints AIa; Litvinenko AA; Bachinskaia NIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1374-8. PubMed ID: 4072540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled testing of vincamine with special reference to the flow properties of blood].
    Klein M; Szobor A; Bräuer H
    Med Klin; 1979 Oct; Suppl():29-36. PubMed ID: 542163
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
    Steinhäuser B
    Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
    [No Abstract]   [Full Text] [Related]  

  • 26. [The correction of microcirculatory disorders in patients with circulatory encephalopathy].
    Vesel'skiĭ ISh; Sanik AV
    Vrach Delo; 1991 Jul; (7):85-7. PubMed ID: 1771847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of "torsade de pointe" during vincamine therapy].
    Richichi I; Valsecchi O; Falcone C; Sofi A; Zanini L
    Minerva Cardioangiol; 1978 Mar; 26(3):197-200. PubMed ID: 652156
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of Cetal in patients with acute confusion].
    Albert E
    Med Klin; 1979 Oct; Suppl():44-5. PubMed ID: 542166
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethyl apovincaminate therapy in neurovascular diseases.
    Szobor A; Klein M
    Arzneimittelforschung; 1976; 26(10a):1984-9. PubMed ID: 1037230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R; Cattani L; Tomasi AM; Masoni A
    Agressologie; 1978; 19(3):221-5. PubMed ID: 736222
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P; Polák O; Ochsenreither AM
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of grandaxin in the complex treatment of patients with initial atherosclerotic encephalopathy].
    Mints AIa; Garmash IuIu; Boĭko NR
    Vrach Delo; 1985 May; (5):96-9. PubMed ID: 4013237
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychoactive effect of vincamine in a group of subjects affected by recurrent depressive syndrome. Preliminary note].
    Crispi G; Di Lorenzo RS; Gentile A; Florino A; Pannone B; Sciorio G
    Minerva Med; 1975 Oct; 66(70):3683-5. PubMed ID: 1103012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
    Ritschel WA; Mandybur TI; Grummich KW; Means ED
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):131-4. PubMed ID: 6748817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental cerebral infarction in Mongolian gerbils: effects of vincamine on lesion size, survival and behavior.
    Ritschel WA; Mandybur TI; Grummich KW; Vorhees CV; Means ED
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):221-42. PubMed ID: 4023410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].
    Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J
    Therapie; 1981; 36(1):55-64. PubMed ID: 7233373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.